Free Trial

iShares Health Innovation Active ETF Rating

$28.13 +0.29 (+1.04%)
As of 04:10 PM Eastern

iShares Health Innovation Active ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

BMED Aggregate Rating

Moderate Buy
2.63

Holdings in BMED have an aggregate rating of Moderate Buy based on 452 analyst ratings issued in the past year covering 21 companies (68.2% of the portfolio).

BMED Aggregate Price Target

$28.13
High Prediction$28.13
Average Prediction$28.13
Low Prediction$28.13

Holdings in BMED have an aggregate price target of $28.13 and a range of $28.13 to $28.13 covering 21 companies (68.2% of the portfolio).

BMED Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
Moderate Buy
15 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
2 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by iShares Health Innovation Active ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 21 BMED Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
7.88%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$225.59
+0.6%
4.921 of 5 stars
2.67$252.48 11.9%27
5.40%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$133.48
+0.6%
4.8337 of 5 stars
2.86$157.35 17.9%28
4.74%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$82.95
-0.5%
4.1839 of 5 stars
2.79$95.65 15.3%28
4.61%
Amgen Inc. stock logo
AMGN
Amgen
$329.59
+1.8%
4.4701 of 5 stars
2.42$357.12 8.4%31
3.92%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$113.21
+0.1%
4.8152 of 5 stars
2.68$128.18 13.2%19
3.63%
Biogen Inc. stock logo
BIIB
Biogen
$189.13
+1.0%
4.0892 of 5 stars
2.50$214.23 13.3%28
3.17%
Waters Corporation stock logo
WAT
Waters
$342.57
+13.5%
3.7781 of 5 stars
2.75$387.53 13.1%20
3.10%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,302.18
+3.3%
2.9934 of 5 stars
2.54$1,459.58 12.1%13
2.95%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$185.27
+7.5%
2.3125 of 5 stars
2.63$205.36 10.8%16
2.95%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$451.38
-0.2%
4.4425 of 5 stars
2.65$581.91 28.9%26
2.92%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$424.36
-1.3%
4.6035 of 5 stars
2.83$554.83 30.7%29
2.85%
argenex SE stock logo
ARGX
argenex
$794.70
-2.0%
3.908 of 5 stars
2.92$1,016.22 27.9%24
2.64%
Moderna, Inc. stock logo
MRNA
Moderna
$46.71
-1.2%
1.138 of 5 stars
1.84$35.73 -23.5%19
2.49%
Pfizer Inc. stock logo
PFE
Pfizer
$26.42
+0.5%
3.9753 of 5 stars
2.23$28.74 8.8%22
2.48%
Danaher Corporation stock logo
DHR
Danaher
$174.69
+0.4%
4.7725 of 5 stars
2.86$240.70 37.8%21
2.33%
Bruker Corporation stock logo
BRKR
Bruker
$38.01
+4.5%
3.495 of 5 stars
2.47$49.38 29.9%15
2.09%
Bio-Techne Corp stock logo
TECH
Bio-Techne
$56.68
+3.5%
4.2604 of 5 stars
2.71$72.77 28.4%14
2.06%
DexCom, Inc. stock logo
DXCM
DexCom
$59.48
-0.9%
4.8247 of 5 stars
2.88$83.50 40.4%24
2.04%
GSK PLC Sponsored ADR stock logo
GSK
GSK
$50.37
-1.0%
3.595 of 5 stars
1.90$53.00 5.2%10
1.99%
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
$99.21
-0.3%
1.7015 of 5 stars
2.80$108.15 9.0%15
1.94%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$466.74
+0.9%
4.918 of 5 stars
3.00$623.05 33.5%23

This page (NYSEARCA:BMED) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners